SEC Filings

Filing date Form Description View
4

Statement of changes in beneficial ownership of securities

View HTML
10-Q

Quarterly report which provides a continuing view of a company's financial position

View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
SC TO-I/A

Amendment to a previously filed SC TO-I

View HTML
SC TO-I/A

Amendment to a previously filed SC TO-I

View HTML
8-K

Report of unscheduled material events or corporate event

View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
SC 13D/A

An amendment to a SC 13D filing

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
SC TO-I

Tender offer schedule and amendment filed by the issuer.

View HTML
8-K

Report of unscheduled material events or corporate event

View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
SC TO-C

Written public communication relating to an issuer or third party tender offer

View HTML

Data provided by Kaleidoscope.

 

 

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.

Shareholder Tools